THE FREQUENCY AND SEVERITY OF PATIENT-REPORTED SYMPTOMS IN GIANT CELL ARTERITIS

THE FREQUENCY AND SEVERITY OF PATIENT-REPORTED SYMPTOMS IN GIANT CELL ARTERITIS

Show other versions (1)

Bibliographic Details
Main Authors:	Monti, S, Leong, A, Robson, J, Craven, A, Merkel, P, Watts, R, Luqmani, R
Format:	Conference item
Published:	Oxford University Press 2017

Similar Items

The frequency and severity of patient-reported symptoms in giant cell arteritis
by: Monti, S, et al.
Published: (2017)

FRI0312 The frequency and severity of patient-reported symptoms in giant cell arteritis
by: Monti, S, et al.
Published: (2017)

The association of vascular risk factors with visual loss in giant cell arteritis
by: Yates, M, et al.
Published: (2016)

O08 Blindness in patients with giant cell arteritis and its association with vascular disease
by: Yates, M, et al.
Published: (2016)

SY4_1 Giant cell arteritis (GCA) and Takayasu arteritis (TAK): a spectrum within the same disease or not? A report from the DCVAS project
by: Luqmani, R, et al.
Published: (2017)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
by: Ponte, C, et al.
Published: (2022)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
by: Ponte, C, et al.
Published: (2022)

Updates on the diagnosis and monitoring of giant cell arteritis
by: Sara Monti, et al.
Published: (2023-02-01)

Giant cell arteritis: Current treatment and management
by: Ponte, C, et al.
Published: (2015)

The role of ultrasound in the management of giant cell arteritis in routine clinical practice
by: Monti, S, et al.
Published: (2017)

PREDICTORS OF AORTIC ANEURYSMS FOR GIANT CELL ARTERITIS SUBJECTS
by: Robson, J, et al.
Published: (2013)

THU0297 A novel ultrasound scoring system for giant cell arteritis
by: Monti, S, et al.
Published: (2017)

The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice
by: Monti, S, et al.
Published: (2017)

THU0302 Histology findings in giant cell arteritis (GCA) and their relationship with the ultrasound results: analysis of data from the tabul study (temporal artery biopsy vs ultrasound in diagnosis of giant cell arteritis)
by: Ponte, C, et al.
Published: (2017)

The United Kingdom and Ireland Vasculitis Registry: Cross-sectional data on the first 3195 patients with a focus on anti-neutrophil cytoplasm – associated vasculitis and giant cell arteritis
by: Luqmani, R, et al.
Published: (2017)

P1_41 Histology findings in giant cell arteritis (GCA) and their relationship with the ultrasound results: analysis of data from the TABUL study (Temporal Artery Biopsy vs Ultrasound in diagnosis of Giant Cell Arteritis)
by: Ponte, C, et al.
Published: (2017)

Treatment of polymyalgia rheumatica and giant cell arteritis: are we any further forward?
by: Luqmani, R
Published: (2007)

THU0296 The role of ultrasound in the management of giant cell arteritis (GCA) in routine clinical practice
by: Monti, S, et al.
Published: (2017)

Tumor necrosis factor-blocking agents in polymyalgia rheumatica and giant cell arteritis - Reply
by: Luqmani, R
Published: (2008)

The use of ultrasound to assess giant cell arteritis: Review of the current evidence and practical guide for the rheumatologist
by: Monti, S, et al.
Published: (2017)

ARE WE MEETING THE STANDARDS FOR TEMPORAL ARTERY BIOPSY IN GIANT CELL ARTERITIS?
by: Soni, A, et al.
Published: (2009)

The role of a standardised ultrasound protocol in the management of giant cell arteritis (GCA) in routine clinical practice
by: Monti, S, et al.
Published: (2017)

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
by: Robson, J, et al.
Published: (2015)

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.
by: Robson, J, et al.
Published: (2015)

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
by: Robson, J, et al.
Published: (2013)

Giant cell arteritis: new concepts, treatments and the unmet need that remains
by: Coath, F, et al.
Published: (2018)

Vascular Endothelial Growth Factor as an Aid to Diagnosis of Giant Cell Arteritis
by: Goodfellow, N, et al.
Published: (2016)

Methotrexate (MTX) failed to control giant cell arteritis (GCA)
by: Hoffman, G, et al.
Published: (2001)

Giant Cell Arteritis of the Breast
by: Nur BÜYÜKPINARBAŞILI, et al.
Published: (2015-12-01)

Giant femoral aneurysm in giant cell arteritis
by: Muhammed Bayram, et al.
Published: (2022-01-01)

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?
by: Goodfellow, N, et al.
Published: (2017)

Giant Cell Arteritis in Ophthalmology Practice: a Case Report
by: V. A. Chernukha, et al.
Published: (2019-03-01)

Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study
by: Robson, J, et al.
Published: (2016)

Advances in the Treatment of Giant Cell Arteritis
by: Santos Castañeda, et al.
Published: (2022-03-01)

FRI0028 Vascular Endothelial Growth Factor as An Aid To Diagnosis of Giant Cell Arteritis
by: Goodfellow, N, et al.
Published: (2016)

Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
by: Matthias Froehlich, et al.
Published: (2023-05-01)

A multinational qualitative study in giant cell arteritis: patient perceptions of diagnosis, treatment, impact on health-related quality of life and contextual factors
by: Robson, J, et al.
Published: (2018)

GIANT-CELL ARTERITIS WITH PERIPHERAL NEUROPATHY
by: Warrell, D, et al.
Published: (1968)

Giant-cell arteritis with peripheral neuropathy.
by: Warrell, D, et al.
Published: (1968)

Treatment of Giant Cell Arteritis (GCA)
by: Alexis Régent, et al.
Published: (2022-03-01)